Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.
Public ClinicalTrials.gov record NCT00500539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Single Arm Study to Assess the Safety and Immunogenicity of Omalizumab Liquid Administered Subcutaneously to Male and Female Adolescents and Adults With Persistent Allergic Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the immunogenic potential of the liquid formulation of omalizumab administered over a period of 6 months in moderate to severe persistent allergic asthma patients 12 years of age or older, with no previous exposure to the drug (omalizumab naïve patients). The secondary objective of this study is to assess the safety of the liquid formulation of omalizumab in the same patients.
Study identification
- NCT ID
- NCT00500539
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Sep 2008 (Actual)
- Completion
- Sep 2008 (Actual)
- Last update posted
- Jun 2, 2011
2007 – 2008
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allergy & Immunology Associates, Ltd | Scottsdale | Arizona | AZ 85251 | — |
| California Allergy and Asthma Medical Group | Palmdale | California | CA 93551 | — |
| Allergy Associates Medical Group, Inc, | San Diego | California | CA 92120 | — |
| Bensch Research Associates | Stockton | California | CA 95207 | — |
| 1st Allergy and Clinical Research Center | Centennial | Colorado | CO 80112 | — |
| Innovative Research of West Florida, Inc. | Largo | Florida | FL 33770 | — |
| Georgia Pollen | Albany | Georgia | GA 31707 | — |
| Kansas City Allergy & Asthma | Overland Park | Kansas | 66210 | — |
| Asthma and Allergy Specialists, PA | Minneapolis | Minnesota | MN 55402 | — |
| : The Clinical Research Center, LLC | St Louis | Missouri | MO 63141 | — |
| Allergy, Asthma and Clinical Immunology | Brick | New Jersey | NJ 08724 | — |
| Asthma & Allergy Research of NJ, Inc. | Mount Laurel | New Jersey | NJ 08054 | — |
| Nassau Chest Pysicians, PC | Massapequa | New York | NY 11758 | — |
| Allergy and Asthma Center of NC, PA | High Point | North Carolina | NC 27262 | — |
| Allergy Center at Brookstone | Columbus | Ohio | OH 31904 | — |
| Toledo Center for Clinical Research | Sylvania | Ohio | OH 43650 | — |
| Asthma and Allergy Center | Toledo | Ohio | OH 43617 | — |
| The Corvallis Clinic, PC | Corvallis | Oregon | OR 97330 | — |
| Allergy, Asthma & Dermatology Research Center | Lake Oswego | Oregon | OR97037 | — |
| Clinical Research Institute of Southern Oregon, PC | Medford | Oregon | OR 97504 | — |
| Allergy & Asthma Specialists, PC | Blue Bell | Pennsylvania | PA 19422 | — |
| Asthma Allergy & Pulmonary Associates, PC | Philadelphia | Pennsylvania | PA 19107 | — |
| AAPRI Clinical Research Institute | Providence | Rhode Island | RI 02906 | — |
| North Texas Institute for Clinical Trials | Fort Worth | Texas | TX 76132 | — |
| Allergy and Asthma Associates | Houston | Texas | TX 77054 | — |
| Clinical Trials of North Houston | Houston | Texas | TX 77070 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00500539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2011 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00500539 live on ClinicalTrials.gov.